Insights into Aβ and presenilin from a canine model of human brain aging

Neurobiology of Disease

Volumn 9, Issue 1, 2002, Pages 1-10

  Head, Elizabeth ^a   Torp, Reidun ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Amyloid; Cognition; Confocal microscopy; Dogs; Electron microscopy; Senile plaques

Indexed keywords

AMYLOID BETA PROTEIN; PRESENILIN 1; MEMBRANE PROTEIN; PSEN1 PROTEIN, HUMAN;

AGE; AGING; BRAIN FUNCTION; CELL MEMBRANE; CORRELATION ANALYSIS; DISEASE MODEL; DOG; ELECTRON MICROSCOPY; HISTOPATHOLOGY; IMMUNOGOLD LABELING; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SENILE PLAQUE; ANIMAL; ANIMAL MODEL; BRAIN; HUMAN; METABOLISM; PATHOLOGY;

AGING; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; DOGS; HUMANS; MEMBRANE PROTEINS; MODELS, ANIMAL; PRESENILIN-1;

EID: 0036008556     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2002.0476     Document Type: Review

References (72)

1. Spatial learning and memory in the dog as a model of cognitive aging
2. DNA damage and apoptosis in the aged canine brain: Relationship to Aβ deposition in the absence of neuritic pathology
3. Molecular dating of senile plaques in aged Down's syndrome and canine brains
4. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abetal-42/1-40 ratio in vitro and in vivo
5. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins
6. Age-related changes in the brain of the dog
7. Neuronal nuclear DNA fragmentation in the aged canine brain: Apoptosis or nuclear DNA fragility?
8. Neuropathological stageing of Alzheimer-related changes
9. Staging of Alzheimer-related cortical destruction
10. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alphasecretase cleavage of the Alzheimer amyloid protein precursor
11. Development of a protocol for studying object recognition memory in the dog
12. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice
13. Alzheimer's ab(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells
14. The neurobiologic consequences of Down syndrome
15. Image analysis of beta-amyloid "load" in Alzheimer's disease and relation to dementia severity
16. Beta-amyloid accumulation correlates with cognitive dysfunction in the aged canine
17. The canine as an animal model of human aging and dementia
18. Diffuse plaques contain C-terminal ABeta 1-42 and not ABeta 1-40: Evidence from cats and dogs
19. The discrepancy between presenilin subcellular localization and gamma-secretase processing of amyloid precursor protein
20. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
21. Analysis of presenilin I and presenilin 2 expression and processing by newly developed monoclonal antibodies
22. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1
23. Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees
24. An immunocolloid method for the electron microscope
25. The presence of isoaspartic acid in β-amyloid plaques indicates plaque age
26. Presenilin structure, function and role in Alzheimer's disease
27. Distinct sites of intracellular production for Alzheimer's disease AB40/42 amyloid peptides
28. Spatial learning and memory as a function of age in the dog
29. Discrimination learning ability and beta amyloid accumulation in the dog
30. Region-specific age at onset of β-amyloid in dogs
31. Neurobiological models of aging in the dog and other vertebrate species
32. Distribution of beta-amyloid in the canine brain
33. Visualization of AB42(43) and AB40 in senile plaques with end-specific AB monoclonals: Evidence that in initially deposited species is AB42(43)
34. Aggresomes: A cellular response to misfolded proteins
35. Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis
36. Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease
37. Diagnosis of Alzheimer's disease
38. Apoptosis in the aged dog brain
39. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease
40. Regional cerebral metabolic rate for glucose in beagle dogs of different ages
41. The pathological association between Down syndrome and Alzheimer disease
42. Organization of AMPA receptor subunits at a glutamate synapse: A quantitative immunogold analysis of hair cell synapses in the rat organ of Corti
43. Cognitive functions and aging in the dog: Acquisition of nonspatial visual tasks
44. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
45. Consortium to establish a registry for Alzheimer's disease (CERAD). Clinical and neuropsychological assessment of Alzheimer's disease
46. Susceptibility locus for Alzheimer's disease in chromosome 10
47. Deposition of amyloid β protein (Aβ) subtypes [Aβ40 and Aβ42(43)] in canine senile plaques and cerebral amyloid angiopathy
48. Quantitative electron microscopic immunocytochemistry of amino acids
49. Mapping the APP/presenilin (PS) binding domains: The hydrophilic N-terminus of PS2 is sufficient for interaction with APP and can displace APP/PS1 interaction
50. Alzheimer's disease: Genetic studies and transgenic models
51. The progression of beta-amyloid deposition in the frontal cortex of the aged canine
52. Influence of fixatives and embedding media in immunolabeling of freeze-substituted cells
53. Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease
54. Normal and abnormal biology of the beta-amyloid precursor protein
55. Neuritic plaque amyloid in Alzheimer's disease is highly racemized
56. Antisera to gamma-aminobutyric acid. III. Demonstration of GABA in Golgi-impregnated neurons and in conventional electron microscopic sections of cat striate cortex
57. MR Imaging of anatomic and vascular characteristics in a canine model of human aging
58. N-terminal heterogeneity of parenchymal and cerebrovascular Aβ deposits
59. Consensus recommendations for the post mortem diagnosis of Alzheimer's disease
60. Stable association of presenilin derivatives and absence of presenilin interactions with APP
61. Ultrastructural evidence of fibrillar β-amyloid associated with neuronal membranes in behaviorally characterized aged dog brains
62. The use of the aged dog for ultrastructural studies of β-amyloid deposition and neuropathology - Recent technical advances
63. Lowicryl K4M embedding of brain tissue for immunogold electron microscopy
64. Silver-intensified gold and peroxidase as dual ultrastructural immunolabels for pre and postsynaptic neurotransmitters
65. Freeze-substitution and Lowicryl HM20 embedding of fixed rat brain: Suitability for immunogold ultrastructural localization of neuronal antigens
66. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE
67. Presenilin 1 binds to amyloid precursor protein directly
68. Senile plaques and cerebral amyloidosis in aged dogs
69. Aged dogs: An animal model to study beta-protein amyloidogenesis
70. Amyloid Beta 1-42 deposits do not lead to Alzheimer's neuritic plaques in aged dogs
71. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity
72. Epidemiology and clinical genetics of Alzheimer's disease